IP Group cheers trial results for Enterprise drug candidate
12th May 2026 11:37
(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms. Read More
(Alliance News) - IP Group PLC on Monday noted positive test results for a cystic fibrosis treatment developed by one of its portfolio firms. Read More
IP Group PLC - London-based investor in "breakthrough" science and technology firms - Appoints Michael Queen as chair designate, and as a non-executive director. Says he will succeed outgoing Chair Douglas Flint at its annual general meeting on June 18, at which point Flint will retire "after almost eight years of service" on the board. Notes that Queen was, until 2012, the chief executive of London-based private equity investor 3i Group PLC, where he had worked for 25 years. Currently, he is chair of UK private equity firm Coller Capital Ltd. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More
(Alliance News) - IP Group PLC on Tuesday highlighted a successful acquisition by portfolio holding Pfizer Inc, as the investor in science and technology companies posted an improved annual performance. Read More
(Alliance News) - Stock prices in London opened mixed on Tuesday, as the FTSE 100 was helped by oil majors to outperform European peers, while Trustpilot shares jumped on strong profit growth. Read More
(Alliance News) - Shares in IP Group PLC rose on Wednesday, as the firm noted its participation in a USD103 million fundraise by Oxa Autonomy Ltd. Read More
Prudential PLC - London-based insurer - Confirms Douglas Flint's appointment as a non-executive director and chair-designate will become effective on March 4. As previously announced, Flint will succeed Shriti Vadera as chair after the annual general meeting on May 28, when Vadera will leave the board. Flint, who has previously chaired Asia-focused lender HSBC Holdings PLC, currently holds the same post at asset manager Aberdeen Group PLC and intellectual property commercialisation firm IP Group PLC. Read More
(Alliance News) - IP Group PLC on Wednesday said portfolio company Microbiotica Ltd has announced positive results from a phase 1b first-in-human trail of MB310 in ulcerative colitis patients. Read More
(Alliance News) - Prudential PLC on Wednesday said it has named Douglas Flint as its next chair, replacing Shriti Vadera, who will round off a roughly five-year stint in the position in May. Read More
IP Group PLC - London-based intellectual property commercialisation firm - Notes that portfolio company Pulmocide announced the termination of the Opera-T phase 3 study for opelconazole in refractory invasive pulmonary aspergillosis, a severe fungal infection of the lungs. Opelconazole is an experimental antifungal drug. IP has a 12.0% holding in Pulmocide valued at GBP28.1 million. Pulmocide, a biopharmaceutical firm, will conduct a thorough review of the unblinded data from the trial to determine potential next steps for the programme. IP adds that it expects to "significantly" reduce the carrying value of the asset and conduct further work as part of the year end process to fully gauge the appropriate level of its adjustment. IP says it "benefits from a strong pipeline of new and maturing companies, as well as a number of valuable licences, and remains confident of delivering meaningful returns for shareholders over the medium term." Read More
IP Group PLC - London-based intellectual property commercialisation firm - Completes GBP20 million extension of GBP75 million share buyback programme on Tuesday. In total, IP Group buys back 158.0 million shares at average 47.5 pence. All the repurchased shares will be cancelled, leaving IP Group with 883.4 million in total. Read More
(Alliance News) - IP Group PLC on Monday reported "potential royalty income" from possible obesity drugs by Metsera Inc. Read More
(Alliance News) - European equities opened higher on Monday, as US-China trade tensions eased following the latest remarks from Donald Trump, just days after a tariff threat. Read More
(Alliance News) - The FTSE 100 index was in the green at midday on Wednesday, after the Office for National Statistics revised down UK government borrowing figures for the current fiscal year by GBP2 billion, following the discovery of an error in the original data. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
(Alliance News) - IP Group PLC on Wednesday reported a narrower half-year loss and said its net asset value had stabilised, pointing to progress in its portfolio and confidence in hitting its target for exits over the next two years. Read More
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: Read More
(Alliance News) - IP Group PLC on Thursday said it has extended its share buyback programme by GBP20 million to a total of GBP75 million. Read More
(Alliance News) - IP Group PLC on Monday said investee AccelerComm has secured USD15 million through a round of funding. Read More